tipo
- journal article
Up-front therapy with CHOP plus etoposide in Brazilian nodal PTCL patients: increased toxicity and no survival benefit compared to CHOP regimen - results of a real-life study from a middle-income country
Documento
- doi:10.1016/j.clml.2022.06.012
- http://dx.doi.org/10.1016/j.clml.2022.06.012
- http://https://www.sciencedirect.com/science/article/abs/pii/S2152265022002166?CMX_ID=&SIS_ID=&dgcid=STMJ_AUTH_SERV_PUBLISHED&utm_acid=80456874&utm_campaign=STMJ_AUTH_SERV_PUBLISHED&utm_in=DM274768&utm_medium=email&utm_source=AC_][doi:10.1016/j.clml.2022.06.012
- https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(22)00216-6/fulltext][doi:10.1016/j.clml.2022.06.012
- Visão geral
- Identidade
- Informação adicional documento
- Outro
- Ver todos
Visão geral
autores
data de publicação
- 2022-01-01